OpenURL Connection Search

Select item for more details and to access through your institution.

Pilot Study to Predict Pharmacokinetics of a Therapeutic Gemcitabine Dose From a Microdose.
Published in:
Clinical Pharmacology in Drug Development, 2020, v. 9, n. 8, p. 929, doi. 10.1002/cpdd.774
By:
- Van Nuland, M.;
- Rosing, H.;
- Thijssen, B.;
- Burgers, J.A.;
- Huitema, A.D.R.;
- Marchetti, S.;
- Schellens, J.H.M.;
- Beijnen, J.H.
Publication type:
Article
Protein kinase C as a target for new anti-cancer agents.
Published in:
Journal of Oncology Pharmacy Practice, 1999, v. 5, n. 4, p. 166, doi. 10.1191/107815599678840525
By:
- van Gijn, R.;
- Zuidema, X.;
- Bult, A.;
- Beijnen, J.H.
Publication type:
Article
Dual topoisomerase I/II inhibitors.
Published in:
Journal of Oncology Pharmacy Practice, 2000, v. 6, n. 3, p. 92, doi. 10.1191/107815500701563317
By:
- van Gijn, R.;
- Lendfers, R.R.H.;
- Schellens, J.H.M.;
- Bult, A.;
- Beijnen, J.H.
Publication type:
Article
Targeted toxins.
Published in:
Journal of Oncology Pharmacy Practice, 1999, v. 5, n. 4, p. 149, doi. 10.1191/107815599678840480
By:
- den Brok, M.W.J.;
- de Gast, G.C.;
- Schellens, J.H.M.;
- Beijnen, J.H.
Publication type:
Article
Pharmacologic study of Cremophor EL in cancer patients with impaired hepatic function receiving paclitaxel.
Published in:
Journal of Oncology Pharmacy Practice, 1999, v. 5, n. 2, p. 83, doi. 10.1191/107815599678847140
By:
- Nannan Panday, V.R.;
- Huizing, M.T.;
- van Tellingen, O.;
- Hakvoort, R.A.;
- Willemse, P.H.B.;
- de Graeff, A.;
- Vermorken, J.B.;
- Beijnen, J.H.
Publication type:
Article
Metabolism and disposition of the anticancer quinolone derivative vosaroxin, a novel inhibitor of topoisomerase II.
Published in:
Investigational New Drugs, 2017, v. 35, n. 4, p. 478, doi. 10.1007/s10637-017-0428-1
By:
- Nijenhuis, C.M.;
- Lucas, L.;
- Rosing, H.;
- Huitema, A.D.R.;
- Mergui-Roelvink, M.;
- Jamieson, G.;
- Fox, J.A.;
- Mould, D.R.;
- Schellens, J.H.M.;
- Beijnen, J.H.
Publication type:
Article
Distribution of ifosfamide and metabolites between plasma and erythrocytes.
Published in:
Biopharmaceutics & Drug Disposition, 2001, v. 22, n. 3, p. 99, doi. 10.1002/bdd.257
By:
- Kerbusch, T.;
- Herben, V.M.M.;
- Jeuken, M-J.J.;
- Ouwerkerk, J.;
- Keizer, H.J.;
- Beijnen, J.H.
Publication type:
Article
A dose-dependent delayed hypersensitivity reaction to acetaminophen after repeated acetaminophen intoxications.
Published in:
Human & Experimental Toxicology, 1998, v. 17, n. 7, p. 406, doi. 10.1191/096032798678908972
By:
- Huitema, A.D.R.;
- Soesan, M.;
- Meenhorst, P.L.;
- Koks, C.H.W.;
- Beijnen, J.H.
Publication type:
Article
A prospective case series of women with estrogen receptor-positive breast cancer: levels of tamoxifen metabolites in controlled ovarian stimulation with high-dose tamoxifen.
Published in:
Human Reproduction, 2013, v. 28, n. 4, p. 953, doi. 10.1093/humrep/des445
By:
- Balkenende, E.M.E.;
- Dahhan, T.;
- Linn, S.C.;
- Jager, N.G.L.;
- Beijnen, J.H.;
- Goddijn, M.
Publication type:
Article
Evaluation of clinical pharmacist interventions on drug interactions in outpatient pharmaceutical HIV-care.
Published in:
Journal of Clinical Pharmacy & Therapeutics, 2004, v. 29, n. 2, p. 121, doi. 10.1111/j.1365-2710.2003.00541.x
By:
- de Maat, M.M.R.;
- de Boer, A.;
- Koks, C.H.W.;
- Mulder, J.W.;
- Meenhorst, P.L.;
- van Gorp, E.C.M.;
- Mairuhu, A.T.A.;
- Huitema, A.D.R.;
- Beijnen, J.H.
Publication type:
Article
ET-743: A Viewpoint by Jos H. Beijnen and Jan H.M. Schellens.
Published in:
Drugs, 2002, v. 62, n. 8, p. 1193
By:
- Beijnen, J.H.;
- Schellens, J.H.M.
Publication type:
Article
Pharmacotherapy of Hospitalised HIV-Infected Patients in a General Hospital during 1990, 1997 and 2001.
Published in:
Clinical Drug Investigation, 2003, v. 23, n. 1, p. 45, doi. 10.2165/00044011-200323010-00006
By:
- de Maat, M.M.R.;
- Post, T.M.;
- Jonker, D.M.;
- Mulder, J.W.;
- Meenhorst, P.L.;
- van Gorp, E.C.M.;
- Koks, C.H.W.;
- de Boer, A.;
- Beijnen, J.H.
Publication type:
Article
Carboplatin Dosage Formulae Can Generate Inaccurate Predictions of Carboplatin Exposure in Carboplatin/Paclitaxel Combination Regimens.
Published in:
Clinical Drug Investigation, 1998, v. 15, n. 4, p. 327, doi. 10.2165/00044011-199815040-00009
By:
- Nannan Panday, V.R.;
- van Warmerdam, L.J.C.;
- Huizing, M.T.;
- ten Bokkel Huinink, W.W.;
- Vermorken, J.B.;
- Giaccone, G.;
- Veenhof, C.H.N.;
- Schellens, J.H.M.;
- Beijnen, J.H.
Publication type:
Article
Proceedings of the Dutch Society for Clinical Pharmacology and Biopharmacy, 16 April 2004.
Published in:
2005
By:
- Bosch, T.M.;
- Kjellberg, L.M.;
- Meijerman, I.;
- Smits, P.H.M.;
- Schellens, J.H.M.;
- Beijnen, J.H.
Publication type:
Letter
Erratum.
Published in:
2003
By:
- Callies, S.;
- de Alwis, D.P.;
- Harris, A.;
- Vasey, P.;
- Beijnen, J.H.;
- Schellens, J.H.;
- Burgess, M.;
- Aarons, L.
Publication type:
Correction Notice
The steady -state pharmacokinetics of saquinavir (SQV-SGC, Fortovase<sup>TM</sup>) 1,000 mg twice daily in combination with ritonavir (RIT) 100 mg twice daily in HIV-1-infected individuals after a normal and a high-fat breakfast.
Published in:
British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 497P
By:
- Veldkamp, A.I.;
- Van Heeswijk, R.P.G.;
- Mulder, J.W.;
- Meenhorst, P.L.;
- Schreij, G.;
- Van Der Geest, S.;
- Beijnen, J.H.;
- Lange, J.M.A.;
- Hoetelmans, R.M.W.
Publication type:
Article
The pharmacokinetics (PK) of combined once daily nevirapine (NVP) and efavirenz (EFV).
Published in:
British Journal of Clinical Pharmacology, 2000, v. 50, n. 5, p. 495
By:
- Veldkamp, A.I.;
- Hoetelmans, R.M.W.;
- Beijnen, J.H.;
- Harris, M.;
- Montaner, J.S.G.;
- Youle, M.;
- Hutman, W.;
- Gazzard, B.;
- Carlier, H.;
- Kwakkelstein, M.O.;
- Lange, J.M.A.;
- Reiss, P.
Publication type:
Article
A mechanism-based pharmacokinetic model for the interaction between thiotepa and cyclophosphamide.
Published in:
British Journal of Clinical Pharmacology, 2000, v. 50, n. 5, p. 496
By:
- Huitema, A.D.R.;
- Mathôt, R.A.A.;
- Tibben, M.M.;
- Schellens, J.H.M.;
- Rodenhuis, S.;
- Beijnen, J.H.
Publication type:
Article
Pharmacokinetics and pharmacodynamics of the novel marine derived agent Ecteinascidin 743 in a phase 1 dose finding study.
Published in:
British Journal of Clinical Pharmacology, 2000, v. 50, n. 5, p. 489
By:
- Van Kesteren, C.H.;
- Cvitkovic, E.;
- Misset, J.L.;
- Teaume, K.;
- Jimeno, J.M.;
- Lopez-Lazaro, L.;
- Guzman, C.;
- Mathôt, R.A.A.;
- Schellens, J.H.M.;
- Brain, E.;
- Hillebrand, M.J.X.;
- Rosing, H.;
- Beijnen, J.H.
Publication type:
Article
Evaluation of the autoinduction of ifosfamide metabolism by a population pharmacokinetic approach using NONMEM.
Published in:
British Journal of Clinical Pharmacology, 2000, v. 49, n. 6, p. 555, doi. 10.1046/j.1365-2125.2000.00217.x
By:
- Kerbusch, T.;
- Huitema, A.D.R.;
- Ouwerkerk, J.;
- Keizer, H.J.;
- Mathôt, R.A.A.;
- Schellens, J.H.M.;
- Beijnen, J.H.
Publication type:
Article
Drug interactions between antiretroviral drugs and comedicated agents.
Published in:
2003
By:
- de Maat, M.M.R.;
- Ekhart, G.C.;
- Huitema, A.D.R.;
- Koks, C.H.W.;
- Mulder, J.W.;
- Beijnen, J.H.;
- de Maat, Monique M R;
- Ekhart, G Corine;
- Huitema, Alwin D R;
- Koks, Cornelis H W;
- Mulder, Jan W;
- Beijnen, Jos H
Publication type:
journal article
Population pharmacokinetics of ifosfamide and its dechloroethylated and hydroxylated metabolites in children with malignant disease: a sparse sampling approach.
Published in:
2001
By:
- Kerbusch, T.;
- de Kraker, J.;
- Mathôt, R.A.A.;
- Beijnen, J.H.;
- Mathĵt, R A
Publication type:
journal article
Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites.
Published in:
2001
By:
- Kerbusch, T.;
- de Kraker, J.;
- Keizer, H.J.;
- van Putten, J.W.G.;
- Groen, H.J.M.;
- Jansen, R.L.H.;
- Schellens, J.H.M.;
- Beijnen, J.H.;
- van Putten, J W;
- Groen, H J;
- Jansen, R L;
- Schellens, J H
Publication type:
journal article
Pharmacokinetically guided administration of chemotherapeutic agents.
Published in:
2000
By:
- van den Bongard, H.J.G.D.;
- Mathôt, R.A.A.;
- Beijnen, J.H.;
- Schellens, J.H.M.;
- van den Bongard, H J;
- Mathôt, R A;
- Schellens, J H
Publication type:
journal article
A Phase 1 Comparative Pharmacokinetic and Cardiac Safety Study of Two Intravenous Formulations of CO-101 in Patients With Advanced Solid Tumors.
Published in:
Journal of Clinical Pharmacology, 2013, v. 53, n. 8, p. 878, doi. 10.1002/jcph.108
By:
- Stuurman, F.E.;
- Lolkema, M.P.;
- Huitema, A.D.R.;
- Soetekouw, P.M.M.B.;
- Rosing, H.;
- Rolfe, L.;
- Kaur, P.;
- Beijnen, J.H.;
- van Tinteren, H.;
- Voest, E.E.;
- Schellens, J.H.M.
Publication type:
Article
P-glycoprotein and Mrp1 collectively protect the bone marrow from vincristine-induced toxicity in vivo.
Published in:
2003
By:
- van Tellingen, O.;
- Buckle, T.;
- Jonker, J.W.;
- van der Valk, M.A.;
- Beijnen, J.H.
Publication type:
journal article
Potentiation of anti-cancer drug activity at low intratumoral pH induced by the mitochondrial inhibitor m-iodobenzylguanidine (MIBG) and its analogue benzylguanidine (BG).
Published in:
British Journal of Cancer, 1999, v. 79, n. 5/6, p. 793, doi. 10.1038/sj.bjc.6690127
By:
- Kuin, A.;
- Aalders, M.;
- Lamfers, M.;
- van Zuidam, D.J.;
- Essers, M.;
- Beijnen, J.H.;
- Smets, L.A.
Publication type:
Article
Bioavailability and toxicity after oral administration of m-iodobenzylguanidine (MIBG).
Published in:
British Journal of Cancer, 1999, v. 79, n. 5/6, p. 802, doi. 10.1038/sj.bjc.6690128
By:
- Kuin, A.;
- Rutgers, M.;
- van der Valk, M.A.;
- Beijnen, J.H.;
- Smets, L.A.
Publication type:
Article
Vemurafenib en dabrafenib in combinatie met radiotherapie en het risico op verergerde radiotoxiciteit.
Published in:
Nederlands Platform voor Farmaceutisch Onderzoek, 2018, p. 1
By:
- de Vries Schultink, A.H.M.;
- Koomen, J.;
- van Triest, B.;
- Hendrikx, J.J.M.A.;
- Haanen, J.B.A.G.;
- Beijnen, J.H.;
- Huitema, A.D.R.
Publication type:
Article

Found: 29